What Medtronic's 8-K filings say: 4 filings, latest Sep 17, 2026
Medtronic filed its latest 8-K with the SEC on Sep 17, 2026. It discusses restructuring, restructuring charge and spinoff.
Public (MDT)Medical Equipment Manufacturing10,000+ employeesmedtronic.comLinkedIn
- Filed
- Sep 17, 2026
- Filings
- 4
- Signals
- 15
8-K · latest 9
What Medtronic's 8-K filings say
- SEC EDGAR
8-K
Filed · 3 signals
Medtronic initiates spin-off of its MiniMed business unit via an exchange offer
Medtronic is separating its MiniMed Group business, creating a new standalone public company.
2%
Potential oversubscription amount for the exchange offer, representing up to two percent of total outstanding Medtronic Ordinary Shares.
D.F. King & Co., Inc.
- SEC EDGAR
8-K
Filed · 3 signals
Dr. Thompson will likely re-evaluate current projects, budgets, and technology partners as he takes over from the departing Brett Wall, who will transition out by September 1, 2026.
- SEC EDGAR
8-K
Filed · 3 signals
- SEC EDGAR
8-K
Filed · 6 signals
Medtronic cuts FY2026 EPS guidance by ~$0.12 due to MiniMed subsidiary costs.
The company lowered its full-year EPS guidance from a range of $5.62-$5.66 to $5.50-$5.54, citing a $157M charge and IPO dilution related to its MiniMed subsidiary.
2.1%
Approximate percentage decrease in the midpoint of FY2026 EPS guidance.
Blackstone Life Sciences Advisors L.L.C.
The earlier-than-expected FDA clearance for its next-gen smartphone-controlled insulin pump forces an accelerated commercial launch.
$157M
One-time charge in Q4 FY2026 related to future royalty payments for MiniMed Flex™ development.
smartphone-controlled devicesBlackstone Life Sciences Advisors L.L.C.
This event also triggered a significant financial charge and a revision of FY26 earnings guidance.
smartphone-controlled insulin pumpBlackstone Life Sciences Advisors L.L.C.
Medtronic to recognize a $157M one-time charge in Q4 FY2026 related to MiniMed product launch.
A one-time charge of $157M will be recognized due to accelerated payments to R&D partner Blackstone, triggered by early FDA approval of the MiniMed Flex pump.
$157M
One-time charge related to future payments to Blackstone for MiniMed Flex development.
Blackstone Life Sciences Advisors L.L.C.
Medtronic subsidiary MiniMed completes 10% IPO, causing $0.04 EPS dilution in Q4 FY26.
The recent IPO of 10% of the MiniMed subsidiary creates a new public company and introduces financial complexity for Medtronic, including a $0.04 per share dilutive impact in Q4.
10%
Portion of MiniMed subsidiary sold in an initial public offering (IPO).
Showing 9 of 15 filing signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Medtronic with the Signal API
One POST /v1/companies/enrich call with medtronic.com returns Medtronic 8-K signals (sec-8k), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"medtronic.com","signal_types":["sec-8k"],"limit":20}'Same industry
8-K at related companies
Questions about Medtronic 8-K
When did Medtronic file its latest 8-K?
What did Medtronic disclose in its latest 8-K?
Where can I read Medtronic's 8-K filing?
Source. Current reports (Form 8-K) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .